Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework

E. E. Wolters, A. Dodich, M. Boccardi, J. Corre, A. Drzezga, O. Hansson, A. Nordberg, G. B. Frisoni, V. Garibotto, R. Ossenkoppele

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework'. Together they form a unique fingerprint.

Medicine & Life Sciences